UNITE4TB (PHASE II)
Support the early phase clinical trials of novel anti-tuberculosis drugs for drug-resistant tuberculosis on a worldwide platform.
We analysed the toxicity of novel drug combinations to ensure patient safety.
Collaborators: Gerry Davies, Andrea Jorgensen, Dan Carr, Elin Svensson (Uppsala), Raman Sharma (GSK)
Postdoc Scientist: Huang Zhonghui